Amphastar Pharmaceuticals (AMPH) Net Margin (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Net Margin of 3.75% for Q1 2026, down 1108.0% year-over-year from 0.37% in Q1 2025, and down 85.57% quarter-over-quarter from 25.99% in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Net Margin (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Net Margin history runs 14 years deep, the most recent figure standing at 3.75% for Q1 2026.
- In Q1 2026, Net Margin fell 1108.0% year-over-year to 3.75%; the TTM figure through Mar 2026 stood at 14.21% (down 517.0% YoY), while the FY2025 annual figure was 16.84%, down 503.0% from the prior year.
- Net Margin for Q1 2026 stood at 3.75%, down from 25.99% in the prior quarter.
- The five-year high for Net Margin was 27.48% in Q3 2023, with the low at 81.55% in Q4 2023.
- The 5-year median for Net Margin is 19.15% (2023), against an average of 12.7%.
- The sharpest annual moves came in 2023 and 2024: Net Margin tumbled 10671 bps in 2023, then surged 10191 bps in 2024.
- Amphastar Pharmaceuticals' Net Margin stood at 25.16% in 2022, then tumbled by 424 bps to 81.55% in 2023, then soared by 125 bps to 20.35% in 2024, then increased by 28 bps to 25.99% in 2025, then slumped by 86 bps to 3.75% in 2026.
- Business Quant data shows AMPH's Net Margin at 3.75% in Q1 2026, 25.99% in Q4 2025, and 9.04% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 933.76 Mn | 643.64 Mn | 93.47 Mn | 16.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.50% |
| Mar 31, 2026 | 3.75% |
| Dec 31, 2025 | 25.99% |
| Sep 30, 2025 | 9.04% |
| Jun 30, 2025 | 17.79% |
| Mar 31, 2025 | 14.83% |
| Dec 31, 2024 | 20.35% |
| Sep 30, 2024 | 21.14% |
| Jun 30, 2024 | 20.81% |
| Mar 31, 2024 | 25.46% |
| Dec 31, 2023 | -81.55% |
| Sep 30, 2023 | 27.48% |
| Jun 30, 2023 | 18.14% |
| Mar 31, 2023 | 19.15% |
| Dec 31, 2022 | 25.16% |
| Sep 30, 2022 | 13.35% |
| Jun 30, 2022 | 14.25% |
| Mar 31, 2022 | 20.73% |
| Dec 31, 2021 | 16.52% |
| Sep 30, 2021 | 27.59% |